sec filing
NASDAQ · BNGO
Bionano Genomics, Inc.
Healthcare · Medical - Diagnostics & Research
$1.56
Up+$0.23 (+17.29%)
Updated Sep 16, 2026, 8:37 AM
SID Score
3.5/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 5.48M
- P/E ratio
- -0.23
- Dividend yield
- 0.00%
- 52-week range
- $1.00 – $2.16
- Volume
- 39.78M
- Avg. volume
- 721.42K
Price performance
BNGO price history
1M range · 20 trading sessions · Daily adjusted prices
BNGO closed at $1.56 after 20 trading sessions, up 32.20% for the selected period.
- Last close
- $1.56
- Period change
- +32.20%
- Period low
- $1.17
- Period high
- $1.56
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 15, 2026 | $1.31 | $2.23 | $1.31 | $1.56 | 39.78M |
| Sep 14, 2026 | $1.23 | $1.38 | $1.2143 | $1.33 | 409.55K |
| Sep 11, 2026 | $1.21 | $1.24 | $1.20 | $1.22 | 57.99K |
| Sep 10, 2026 | $1.18 | $1.24 | $1.16 | $1.20 | 288.14K |
| Sep 9, 2026 | $1.19 | $1.22 | $1.18 | $1.18 | 69.46K |
| Sep 8, 2026 | $1.21 | $1.2263 | $1.185 | $1.20 | 87.37K |
| Sep 4, 2026 | $1.25 | $1.25 | $1.195 | $1.20 | 177.45K |
| Sep 3, 2026 | $1.27 | $1.28 | $1.23 | $1.24 | 191.72K |
| Sep 2, 2026 | $1.22 | $1.28 | $1.2038 | $1.27 | 300.73K |
| Sep 1, 2026 | $1.21 | $1.22 | $1.17 | $1.22 | 208.66K |
| Aug 31, 2026 | $1.18 | $1.22 | $1.15 | $1.22 | 177.4K |
| Aug 28, 2026 | $1.23 | $1.24 | $1.16 | $1.17 | 179.63K |
| Aug 27, 2026 | $1.21 | $1.25 | $1.20 | $1.21 | 168.13K |
| Aug 26, 2026 | $1.24 | $1.26 | $1.205 | $1.21 | 157.09K |
| Aug 25, 2026 | $1.22 | $1.26 | $1.201 | $1.25 | 115.65K |
| Aug 24, 2026 | $1.22 | $1.25 | $1.18 | $1.22 | 133.38K |
| Aug 21, 2026 | $1.22 | $1.26 | $1.18 | $1.20 | 193.21K |
| Aug 20, 2026 | $1.22 | $1.24 | $1.19 | $1.21 | 111.53K |
| Aug 19, 2026 | $1.18 | $1.25 | $1.18 | $1.23 | 245.82K |
| Aug 18, 2026 | $1.21 | $1.21 | $1.14 | $1.18 | 180.74K |
Latest BNGO news
The latest Smart Investors Daily articles mentioning BNGO.
Stock researchCompany · Overview
BNGO research
Overview
Company profile and research snapshot.
Company profile
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in the Americas, EMEA, and Asia Pacific, of which the EMEA region generates the majority of its revenue. It generates product revenue from sales of its OGM and Ionic Purification systems and consumables, which include its instruments and their VIA software.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- $46.50
- Implied upside
- —
- Analysts
- —
| Date | Firm | Rating | Target |
|---|---|---|---|
| Apr 13, 2026 | HC Wainwright & Co. | Buy | — |
| Nov 24, 2025 | HC Wainwright & Co. | Buy | — |
| Aug 18, 2025 | HC Wainwright & Co. | Buy | — |
| May 20, 2025 | Maxim Group | Buy | — |
| Apr 9, 2025 | HC Wainwright & Co. | Buy | — |
News briefing
Data unavailable
Market data is busy. Please try again shortly.
AI research layers
Interpretive context generated from the platform’s current data sources.
Data unavailable
Market data is busy. Please try again shortly.